Project Grant F32AI186447
Award Date
1/15/25
Completion Date
9/30/25
Dollars Obligated
$148K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Similar Awards
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to define the functional role of lung microfold (M) cells in predisposition to influenza-associated pneumococcal invasion and pneumonia. The $342,900 award, with a performance period from September 1, 2024 to September 30, 2026, aims to investigate the intracellular trafficking mechanisms during pneumococcal...
This $728,497 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research at Idaho State University from August 2022 through July 2025 on the role of metal ion homeostasis in regulating bacterial capsule production. The goal is to identify the molecular mechanisms by which cellular ratios of manganese, zinc, and calcium influence capsule polysaccharide production in Streptococcus pneumoniae, a gram-positive pathogen. Researchers...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,310 to Duke University to investigate the mucin utilization capabilities of the gut microbe Akkermansia muciniphila. The research aims to identify the genetic determinants and biological mechanisms that enable A. muciniphila to thrive within the gastrointestinal mucin layer, which is critical for...
The University of Alabama at Birmingham (UAB) received a $216,068 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, with an award date of November 8, 2024 and a completion date of October 31, 2026, supports research to understand the role of the PRP protease and L27 cleavage in the Streptococcus pneumoniae ribosome. The key objectives are to define the role of PRP and L27...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $226,253 Project Grant (Award ID: R21AI188434) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. The grant supports research focused on understanding how the host protein ADAM10 modulates the interaction between neutrophils and the endothelium during Staphylococcus aureus infection. The research will leverage transgenic mouse models, in vivo imaging, and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $189,150 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to elucidate the molecular mechanisms of the Streptococcus pneumoniae high temperature requirement A (HtrA) enzyme. The research aims to determine the structural rearrangements and dynamics of the S....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $162,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis to characterize the role of plasmacytoid dendritic cells (pDCs) in Mycobacterium tuberculosis (MTB) infection. The project aims to quantify pDC lung trafficking during MTB infection, identify the chemokine receptor required for pDC lung homing, and define pDC's contribution to MTB...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will provide $239,348 to support research at Columbia University investigating the impact of regulatory T cells (Tregs) on host susceptibility to Pseudomonas aeruginosa infection. The goal is to evaluate whether Tregs protect against P. aeruginosa pneumonia by altering the airway metabolome composition and reducing metabolites...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,169 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The grant supports research focused on advancing the PI's expertise in mentoring trainees in antimicrobial resistance (AMR) research. Specifically, the PI plans to expand their knowledge of molecular mechanisms of resistance, incorporating site-directed mutagenesis and pharmacodynamic...
This federal Project Grant award for $820,623.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the genetic determinants regulating the master transcriptional regulator SPI1 in human germinal center B cells. The research aims to identify non-coding regulatory elements, delineate the effects of SPI1 coding variants on autoregulation and expression, and...